The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT05780814
- Status
- Recruiting
Conditions
- Breast Cancer
- Insomnia
- Weight Gain
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive-Behavioral Therapy for Insomnia (CBT-I) — BEHAVIORALThe CBT-I intervention is a 6-session intervention spread out over 8 weeks that combines education and behavioral techniques to reduce insomnia.
- Sleep Education Control (EDU) — BEHAVIORALSubjects will be instructed to read and review select publications from the American Academy of Sleep Medicine
Study Details
The investigators propose a randomized controlled clinical trial in 250 women with a history of early stage breast cancer who are overweight or obese with insomnia to test whether a brief, cognitive-behavioral intervention for insomnia (CBT-I) prior to behavioral weight loss (CBT-I+BWL) is superior to a sleep education control (EDU) condition followed by behavioral weight loss (EDU+BWL). The investigators will measure outcomes at baseline, 8 weeks (after completing CBT-I or EDU and prior to BWL), and at 3, 6, and 12 months.
Key Dates
- Start date
- Feb 1, 2024
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cognitive-Behavioral Therapy for Insomnia (CBT-I)The proposed intervention consists of 6 remotely-delivered sessions; Weeks 1, 2, 4, 6, 7, and 8, with weeks 3 and 5 being "rest weeks". Session 1 will be 60-90 mins, Session 2 will be \~60 mins, and remaining visits are \~45 mins. The investigators propose a methodological innovation for CBT-I, which involves conducting 15-minute sessions every other month during the BWL intervention. Prior to these maintenance sessions, participants in the CBT-I+BWL group will complete electronic sleep diaries for one week and interventionists will use this information in sessions to sustain and enhance long-term outcomes by using MI to reinforce application of CBT-I session content.
- Placebo Comparator: Sleep Education Control (EDU)The EDU intervention will parallel the CBT-I intervention in number, format and length of all sessions, including maintenance sessions. It provides basic information about sleep and cancer, widely available to the public. EDU content does not include any individualized behavioral instructions, sleep diary monitoring during the intervention, or behavior change counseling. Content is presented didactically only.
Primary Outcome Measure
Change in Weight (pounds) [ Time Frame: Baseline (randomization); 8 weeks post-sleep intervention (prior to BWL); and at 3, 6, and 12 months post-BWL. ]
Central Contacts
- Janelle Wilder Coughlin, PHD(410) 550-7000
- Katie Smith, BA(410) 550-8099
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sibley Memorial Hospital | Washington D.C. | District of Columbia | 20016 | Janelle Wilder Coughlin, PHD (PRINCIPAL_INVESTIGATOR) Michael Smith, PHD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins Bayview | Baltimore | Maryland | 21224 | Janelle Wilder Coughlin, PHD (PRINCIPAL_INVESTIGATOR) Michael Smith, PHD (PRINCIPAL_INVESTIGATOR) |
| Sidney Kimmel Comprehensive Cancer Center, the Avon Foundation Breast Center at Johns Hopkins | Baltimore | Maryland | 21218 | Janelle Wilder Coughlin, PHD (PRINCIPAL_INVESTIGATOR) Michael Smith, PHD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins Kimmel Cancer Center at Greenspring Station | Lutherville | Maryland | 21093 | Janelle Wilder Coughlin, PHD (PRINCIPAL_INVESTIGATOR) Michael Smith, PHD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
Related Studies
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama